Regarding other cellular and molecular prognostic markers, we observed an association between high lnc-IRF2-3 levels with CD38-positivity, which was also reported by Ronchetti et al. (but not by El-Khazragy et al.), as well as with the IGHV-unmutated CLL subtype, as was reported in both previous studies [31,53]. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.